Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M.ª J. Duart-Duart"'
Publikováno v:
Farmacia Hospitalaria, Vol 38, Iss 3, Pp 154-161 (2014)
Objective: To evaluate the in vitro physicochemical stability of oxaliplatin anddoxorubicin when the in vivo hyperthermic intraperitoneal conditions arereproduced. Methods: Three solutions were prepared, A (oxaliplatin 200 mg/L), B(doxorubicin 15 mg/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::e90905924c1df18c10f8edc9a14ab9bf
http://www.aulamedica.es/fh/pdf/1170.pdf
http://www.aulamedica.es/fh/pdf/1170.pdf
Autor:
Juan Jose Perez-Ruixo, M.ª J. Duart-Duart, V. Escudero-Ortiz, Amelia Ramon-Lopez, B. Valenzuela
Publikováno v:
Farmacia Hospitalaria. 36:194-206
Objective: To develop and internally validate a population pharmacokinetic model for gemcitabine and its metabolite 2’,2’-difluorodeoxyuridine (dFdU); and to evaluate its predictive perfomance for personalizing the dosage used in cancer patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd78bb334c055c4aa5890e4e6cf36854
https://doi.org/10.1016/j.farma.2011.04.002
https://doi.org/10.1016/j.farma.2011.04.002
Autor:
Belén Valenzuela, Joseba Rebollo, Manuel Sureda González, M.ª J. Duart-Duart, V. Escudero-Ortiz, Antonio Brugarolas
Publikováno v:
Journal of Clinical Oncology. 28:e13015-e13015
e13015 Background: Therapeutic drug monitoring (TDM) is not routinely used for chemotherapy agents. Nonetheless, TDM has the potential to improve the clinical benefit of chemotherapy agents due to ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c15ceb0376447e740b6e9e768e8e100d
https://doi.org/10.1200/jco.2010.28.15_suppl.e13015
https://doi.org/10.1200/jco.2010.28.15_suppl.e13015